
Burjeel Holdings
Categories
$3.74B
Marketcap
UNITED ARAB EMIRATES
Country

H.E. Ahmed Jasim Yousuf Naser Alzaabi (Vice-Chairman)
Dr Thani bin Ahmed Al Zeyoudi (Non-Executive Director)
Mr. Omran Mohammedsaleh AlKhoori (Executive Director)
Dr. Ghuwaya Mohammed Khuwaidem Abdulla Al-Neyadi (Non-Executive Director)
Pharma and Life Sciences
Summary
Burjeel Holdings, founded by Dr. Shamsheer Vayalil in Abu Dhabi, UAE, is a leading healthcare provider known for its extensive network of hospitals and clinics offering a wide range of medical services. Since its establishment, Burjeel Holdings has rapidly expanded across key cities in the UAE, focusing on state-of-the-art facilities equipped with advanced medical technology and staffed by highly qualified professionals.
The company has achieved recognition for its commitment to quality healthcare, earning accreditations and certifications from reputable international bodies. Burjeel Holdings specialises in various medical disciplines including cardiology, orthopaedics, oncology, and more, consistently introducing advanced treatments and procedures to improve patient outcomes.
Emphasising a patient-centric approach, Burjeel Holdings prioritises personalised care and community engagement through health awareness initiatives and educational programs. The organisation continues to grow strategically through acquisitions and partnerships, enhancing its service offerings and geographical presence.
History
Burjeel Holdings, founded by Dr. Shamsheer Vayalil in Abu Dhabi, UAE, has emerged as a prominent healthcare provider renowned for its extensive network of hospitals and clinics offering a comprehensive range of medical services. Founded in 2007, Burjeel Holdings is one of the leading regional private healthcare service providers in the UAE and MENA, operating as an integrated network across primary, secondary, tertiary and quaternary care. Established with a vision to deliver world-class healthcare within the region, Burjeel Holdings began its journey by focusing on constructing state-of-the-art medical facilities equipped with advanced technology and staffed by highly qualified medical professionals.
Since its inception, Burjeel Holdings has experienced rapid expansion, establishing multiple hospitals and clinics across key cities like Abu Dhabi and Dubai. This growth trajectory was supported by strategic acquisitions and partnerships aimed at enhancing service offerings and expanding geographical reach. These efforts have enabled Burjeel Holdings to cater effectively to a diverse range of medical specialities and patient needs.
Burjeel Holdings has achieved significant milestones, earning recognition for its commitment to quality healthcare through accreditations and certifications from respected international bodies. The organisation has been at the forefront of medical advancements, introducing cutting-edge treatments and procedures in specialised areas such as cardiology, orthopaedics, oncology, and more.
Central to Burjeel Holdings' corporate ethos is a patient-centric approach that emphasises personalised care and superior medical outcomes. The company actively engages in community health initiatives and educational programs, promoting health awareness and wellness among residents of the UAE.
Burjeel Holdings aims to sustain its growth momentum by expanding its network and enhancing its medical capabilities. The organisation continues to invest in healthcare technology, including telemedicine and digital health solutions, to improve accessibility and efficiency in healthcare delivery. Internationally recognised for its innovation and quality, Burjeel Holdings remains dedicated to shaping the healthcare landscape of the UAE and potentially beyond, ensuring continued excellence in patient care and medical services.
Mission
vBurjeel Holdings' mission is to provide exceptional healthcare services through advanced medical expertise and compassionate patient care. As a leading healthcare provider in the UAE, Burjeel Holdings strives to enhance the well-being of individuals and communities by offering comprehensive medical solutions tailored to meet diverse healthcare needs. Through state-of-the-art facilities and a commitment to innovation, Burjeel Holdings aims to set benchmarks in medical excellence, continuously improving healthcare standards and outcomes. By fostering a culture of integrity and professionalism among its highly skilled healthcare professionals, Burjeel Holdings ensures a patient-centric approach that prioritises safety, comfort, and holistic wellness. With a strong emphasis on quality, accessibility, and community engagement, Burjeel Holdings is dedicated to shaping a healthier future for the region and beyond.
Vision
Burjeel Holdings envisions becoming the region's foremost healthcare provider renowned for excellence in medical innovation, patient care, and community health. As a leader in the healthcare industry in the UAE, Burjeel Holdings aims to pioneer advancements in medical technology and treatment modalities, setting new standards of quality and efficiency. By fostering a culture of continuous improvement and collaboration, Burjeel Holdings strives to empower its healthcare professionals to deliver compassionate, personalised care that exceeds patient expectations. The organisation is committed to expanding its network of state-of-the-art facilities and enhancing accessibility to world-class healthcare services across the region. Through strategic partnerships and investments in cutting-edge medical research, Burjeel Holdings aims to address evolving healthcare challenges and improve health outcomes for individuals and communities it serves. With a clear focus on innovation, integrity, and community well-being, Burjeel Holdings is poised to shape the future of healthcare delivery in the UAE and beyond.
Key Team
H.E. Ahmed Jasim Yousuf Naser Alzaabi (Vice-Chairman)
Dr Thani bin Ahmed Al Zeyoudi (Non-Executive Director)
Mr. Omran Mohammedsaleh AlKhoori (Executive Director)
Dr. Ghuwaya Mohammed Khuwaidem Abdulla Al-Neyadi (Non-Executive Director)
Recognition and Awards
Products and Services
Burjeel Holdings offers a comprehensive range of healthcare products and services designed to meet diverse medical needs and ensure patient well-being. Their offerings include:
Hospital Services: Burjeel Holdings operates state-of-the-art hospitals equipped with advanced medical technology and staffed by expert healthcare professionals. Services encompass various medical specialities such as cardiology, oncology, orthopaedics, neurology, and more.
Specialised Clinics: They provide specialised outpatient clinics focusing on specific medical disciplines, offering consultations, diagnostics, and treatments tailored to individual patient requirements.
Emergency Care: Burjeel Holdings ensures round-the-clock emergency services, equipped to handle critical medical emergencies with prompt and efficient care.
Surgical Expertise: Comprehensive surgical services covering a wide range of procedures from routine surgeries to complex interventions performed by highly skilled surgeons.
Diagnostic Imaging: Advanced diagnostic imaging services including MRI, CT scans, ultrasound, and X-rays to facilitate accurate diagnosis and treatment planning.
Rehabilitation Services: Post-operative care and rehabilitation programs designed to aid patients in recovery and improve their overall quality of life.
Wellness Programs: Health and wellness initiatives promoting preventive care, health screenings, and lifestyle management to foster long-term health and vitality.
Telemedicine: Modern telemedicine services enable remote consultations, medical advice, and follow-up care, enhancing accessibility and convenience for patients.
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

H.E. Ahmed Jasim Yousuf Naser Alzaabi (Vice-Chairman)
Dr Thani bin Ahmed Al Zeyoudi (Non-Executive Director)
Mr. Omran Mohammedsaleh AlKhoori (Executive Director)
Dr. Ghuwaya Mohammed Khuwaidem Abdulla Al-Neyadi (Non-Executive Director)
Pharma and Life Sciences